News

Filter

Current filters:

Pharmaceutical

101 to 110 of 96179 results

FDA at last approves weight-management drug Contrave

FDA at last approves weight-management drug Contrave

11-09-2014

After considerable delay, the US Food and Drug Administration late yesterday finally granted approval…

Arena PharmaceuticalsBelviqContraveMetabolicsOrexigen TherapeuticsPharmaceuticalQnexaRegulationTakeda PharmaceuticalsUSAVivus

Palatin licenses certain rights to Richter for bremelanotide

11-09-2014

USA-based Palatin Technologies and Hungary’s largest drugmaker Gedeon Richter have entered into a collaboration…

EuropeGedeon RichterLicensingPalatin TechnologiesPharmaceuticalWomen's Health

US Pharma now developing 44 drugs/vaccines for HIV/AIDS

11-09-2014

The USA’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for…

Anti-viralsPharmaceuticalResearchUSAVaccines

Norgine sells certain rights for Camcolit and Somnite to Essential Pharma

11-09-2014

Netherlands-headquartered independent drugmaker Norgine has agreed to sell all rights in the UK for Somnite…

Essential PharmaIrelandLicensingNeurologicalNorginePharmaceuticalUK

Alleviating the health system burden with self-management

Alleviating the health system burden with self-management

11-09-2014

We take a look at the week's top stories.

PoliticsResearch

Positive new data for AbbVie’s Humira in HS

Positive new data for AbbVie’s Humira in HS

11-09-2014

US pharma group AbbVie has released results from a Phase III pivotal study demonstrating that its blockbuster…

AbbVieAnti-Arthritics/RheumaticsDermatologicalsHumiraPharmaceuticalResearch

MabVax links with Memorial Sloan Kettering and Juno on anti-cancer therapeutics

MabVax links with Memorial Sloan Kettering and Juno on anti-cancer therapeutics

11-09-2014

Clinical stage oncology drug development company MabVax Therapeutics has entered agreements with Memorial…

BiotechnologyCancer therapeuticsChimeric antigen receptorMabVax TherapeuticsOncologyResearchUSA

Ario Pharma acquires PharmEste’s TRPA1 research assets

11-09-2014

Cambridge, UK-based biopharma company Ario Pharma says it has acquired the TRPA1 antagonist research…

Ario PharmaInflammatory diseasesMergers & AcquisitionsPharmaceuticalPharmEsteRespiratory and Pulmonary

101 to 110 of 96179 results

Back to top